English  |  正體中文  |  简体中文  |  Total items :0  
Visitors :  51919864    Online Users :  1148
Project Commissioned by the Ministry of Education
Project Executed by National Taiwan University Library
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
About TAIR

Browse By

News

Copyright

Related Links

"lu y s"

Return to Browse by Author
Sorting by Title Sort by Date

Showing items 96-120 of 467  (19 Page(s) Totally)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2021-09-01T01:54:18Z Fractionated evaluation of immunohistochemical hormone receptor expression enhances prognostic prediction in breast cancer patients treated with tamoxifen as adjuvant therapy Lin C.-H.; Lien H.-C.; Hu F.-C.; Lu Y.-S.; Kuo S.-H.; Wu L.-C.; You S.-L.; ANN-LII CHENG; Chang K.-J.; Huang C.-S.
臺大學術典藏 2021-09-01T01:54:16Z Predictive and prognostic values of tau and ERCC1 in advanced breast cancer patients treated with paclitaxel and cisplatin Shao Y.-Y.; Kuo K.-T.; Hu F.-C.; Lu Y.-S.; Huang C.-S.; Liau J.-Y.; Lee W.-C.; Hsu C.; Kuo W.-H.; Chang K.-J.; Lin C.-H.; ANN-LII CHENG
臺大學術典藏 2021-09-01T01:54:14Z Vinorelbine plus 24-hour infusion of high-dose 5-fluorouracil and leucovorin as effective palliative chemotherapy for breast cancer patients with acute disseminated intravascular coagulation Lin P.-H.; Lu Y.-S.; Lin C.-H.; Chang D.-Y.; Huang C.-S.; ANN-LII CHENG; Yeh K.-H.
臺大學術典藏 2021-09-01T01:54:14Z O6-Methylguanine-DNA methyltransferase expression and prognostic value in brain metastases of lung cancers Wu P.-F.; Kuo K.-T.; Kuo L.-T.; Lin Y.-T.; Lee W.-C.; Lu Y.-S.; Yang C.-H.; Wu R.-M.; Tu Y.-K.; Tasi J.-C.; Tseng H.-M.; Tseng S.-H.; ANN-LII CHENG; Lin C.-H.
臺大學術典藏 2021-09-01T01:54:11Z Combinations of mTORC1 inhibitor RAD001 with gemcitabine and paclitaxel for treating non-Hodgkin lymphoma Chiang C.-T.; Yeh P.-Y.; Gao M.; Chen C.-W.; Yeh L.-C.; Feng W.-C.; Kuo S.-H.; Hsu C.-H.; Lu Y.-S.; ANN-LII CHENG
臺大學術典藏 2021-09-01T01:54:08Z IκB kinases increase Myc protein stability and enhance progression of breast cancer cells Yeh P.-Y.; Lu Y.-S.; Ou D.-L.; ANN-LII CHENG
臺大學術典藏 2021-09-01T01:54:08Z Lack of compensatory pAKT activation and eIF4E phosphorylation of lymphoma cells towards mTOR inhibitor, RAD001 Kuo S.-H.; Hsu C.-H.; Chen L.-T.; Lu Y.-S.; Lin C.-H.; Yeh P.-Y.; Jeng H.-J.; Gao M.; Yeh K.-H.; ANN-LII CHENG
臺大學術典藏 2021-09-01T01:54:07Z Prognostic molecular markers in Women aged 35 years or younger with breast cancer: Is there a difference from the older patients? Lin C.-H.; Lu Y.-S.; Huang C.-S.; Kuo K.-T.; Wang C.-C.; You S.-L.; Lin P.-H.; Chang D.-Y.; Kuo W.-H.; Chang K.-J.; ANN-LII CHENG
臺大學術典藏 2021-09-01T01:54:05Z Lack of efficacy to systemic chemotherapy for treatment of metaplastic carcinoma of the breast in the modern era Chen I.C.; Lin C.H.; Huang C.S.; Lien H.C.; Hsu C.; Kuo W.H.; Lu Y.S.; ANN-LII CHENG
臺大學術典藏 2021-09-01T01:54:02Z Multimodel assessment of BRCA1 mutations in Taiwanese (ethnic Chinese) women with early-onset, bilateral or familial breast cancer Kuo W.-H.; Lin P.-H.; Huang A.-C.; Chien Y.-H.; Liu T.-P.; Lu Y.-S.; Bai L.-Y.; Sargeant A.M.; Lin C.-H.; ANN-LII CHENG; Hsieh F.-J.; Hwu W.-L.; Chang K.-J.
臺大學術典藏 2021-09-01T01:54:02Z Efficacy, safety, and potential biomarkers of thalidomide plus metronomic chemotherapy for advanced hepatocellular carcinoma Shao Y.-Y.; Lin Z.-Z.; Hsu C.; Lee K.-D.; Hsiao C.-H.; Lu Y.-S.; Huang C.-C.; Shen Y.-C.; Hsu C.-H.; ANN-LII CHENG
臺大學術典藏 2021-09-01T01:54:01Z The impact of diabetes mellitus on prognosis of early breast cancer in Asia Chen W.-W.; Shao Y.-Y.; Shau W.-Y.; Lin Z.-Z.; Lu Y.-S.; Chen H.-M.; Kuo R.N.C.; ANN-LII CHENG; Lai M.-S.
臺大學術典藏 2021-09-01T01:54:00Z The emerging epidemic of estrogen-related cancers in young women in a developing Asian country Lin C.-H.; Chen Y.-C.; Chiang C.-J.; Lu Y.-S.; Kuo K.-T.; Huang C.-S.; Cheng W.-F.; Lai M.-S.; You S.-L.; ANN-LII CHENG
臺大學術典藏 2021-09-01T01:53:59Z Radiosensitizing effect of a phenylbutyrate-derived histone deacetylase inhibitor in hepatocellular carcinoma Lu Y.-S.; Chou C.-H.; Tzen K.-Y.; Gao M.; ANN-LII CHENG; Kulp S.K.; Cheng J.C.-H.
臺大學術典藏 2021-09-01T01:53:55Z Dynamics of circulating endothelial cells and endothelial progenitor cells in breast cancer patients receiving cytotoxic chemotherapy Kuo Y.-H.; Lin C.-H.; Shau W.-Y.; Chen T.-J.; Yang S.-H.; Huang S.-M.; Hsu C.; Lu Y.-S.; ANN-LII CHENG
臺大學術典藏 2021-09-01T01:53:53Z The first two lines of chemotherapy for anthracycline-naive metastatic breast cancer: A comparative study of the efficacy of anthracyclines and non-anthracyclines Chen W.-W.; Chang D.-Y.; Huang S.-M.; Lin C.-H.; Hsu C.; Lin M.-H.; Huang C.-S.; Lu Y.-S.; ANN-LII CHENG
臺大學術典藏 2021-09-01T01:53:50Z Clinical significance of ESR1 gene copy number changes in breast cancer as measured by fluorescence in situ hybridisation Lin C.-H.; Liu J.M.; Lu Y.-S.; Lan C.; Lee W.-C.; Kuo K.-T.; Wang C.-C.; Chang D.-Y.; Huang C.-S.; ANN-LII CHENG
臺大學術典藏 2021-09-01T01:53:45Z Phosphorylated insulin-like growth factor-1 receptor (pIGF1R) is a poor prognostic factor in brain metastases from lung adenocarcinomas Wu P.-F.; Huang W.-C.; Yang J.C.-H.; Lu Y.-S.; Shih J.-Y.; Wu S.-G.; Lin C.-H.; ANN-LII CHENG
臺大學術典藏 2021-09-01T01:53:43Z CYP19 genetic polymorphism haplotype aasa is associated with a poor prognosis in premenopausal women with lymph node-negative, hormone receptor-positive breast cancer Kuo S.-H.; Yang S.-Y.; Lien H.-C.; Lo C.; Lin C.-H.; Lu Y.-S.; ANN-LII CHENG; Chang K.-J.; Huang C.-S.
臺大學術典藏 2021-09-01T01:53:40Z Distinct clinicopathological features and prognosis of emerging young-female breast cancer in an east Asian country: A nationwide cancer registry-based study Lin C.-H.; Chuang P.-Y.; Chiang C.-J.; Lu Y.-S.; ANN-LII CHENG; Kuo W.-H.; Huang C.-S.; Lai M.-S.; You S.-L.; Tang C.-H.
臺大學術典藏 2021-08-31T06:42:25Z No increased venous thromboembolism risk in Asian breast cancer patients receiving adjuvant tamoxifen Chen T.W.-W.; Chen H.-M.; Lin C.-H.; Huang C.-S.; ANN-LII CHENG; Lai M.-S.; Lu Y.-S.
臺大學術典藏 2021-08-31T06:42:22Z A phase i study of two dosing schedules of volasertib (BI 6727), an intravenous polo-like kinase inhibitor, in patients with advanced solid malignancies Lin C.-C.; Su W.-C.; Yen C.-J.; Hsu C.-H.; Su W.-P.; Yeh K.-H.; Lu Y.-S.; ANN-LII CHENG; Huang D.C.-L.; Fritsch H.; Voss F.; Taube T.; Yang J.C.-H.
臺大學術典藏 2021-08-31T06:29:51Z A pilot study of bevacizumab combined with etoposide and cisplatin in breast cancer patients with leptomeningeal carcinomatosis Wu P.-F.; Lin C.-H.; Kuo C.-H.; Chen W.-W.; Yeh D.-C.; Liao H.-W.; Huang S.-M.; ANN-LII CHENG; Lu Y.-S.
臺大學術典藏 2021-08-31T06:29:51Z Bevacizumab preconditioning followed by etoposide and cisplatin is highly effective in treating brain metastases of breast cancer progressing from whole-brain radiotherapy Lu Y.-S.; Chen T.W.-W.; Lin C.-H.; Yeh D.-C.; Tseng L.-M.; Wu P.-F.; Rau K.-M.; Chen B.-B.; Chao T.-C.; Huang S.-M.; Huang C.-S.; Shih T.T.-F.; ANN-LII CHENG; Taiwan Breast Cancer Consortium
臺大學術典藏 2021-08-31T06:29:50Z High prevalence of the BIM deletion polymorphism in young female breast cancer in an East Asian country Lin C.-H.; Shen C.-Y.; Lee J.-H.; Huang C.-S.; Yang C.-H.; Kuo W.-H.; Chang D.-Y.; Hsiung C.-N.; Kuo K.-T.; Chen W.-W.; Chen I.-C.; Wu P.-F.; Kuo S.-H.; Chen C.-J.; Lu Y.-S.; ANN-LII CHENG

Showing items 96-120 of 467  (19 Page(s) Totally)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page